跳转至内容
Merck

BP030

二丙酸倍氯米松(氯地米松)

British Pharmacopoeia (BP) Assay Standard

别名:

二丙酸倍氯米松, 9-氯-11β,17,21-三羟基-16β-甲基孕甾-1,4-二烯-3,20-二酮-17,21-二丙酸酯

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
C28H37ClO7
CAS号:
分子量:
521.04
EC號碼:
MDL號碼:
分類程式碼代碼:
41116107
NACRES:
NA.24

等級

pharmaceutical primary standard

API 家族

beclometasone

形狀

solid

儲存期限

limited shelf life, expiry date on the label

製造商/商標名

BP

應用

pharmaceutical
pharmaceutical small molecule

格式

neat

儲存溫度

2-8°C

SMILES 字串

CCC(=O)OCC(=O)[C@@]1(OC(=O)CC)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]12C

InChI

1S/C28H37ClO7/c1-6-23(33)35-15-22(32)28(36-24(34)7-2)16(3)12-20-19-9-8-17-13-18(30)10-11-25(17,4)27(19,29)21(31)14-26(20,28)5/h10-11,13,16,19-21,31H,6-9,12,14-15H2,1-5H3/t16-,19-,20-,21-,25-,26-,27-,28-/m0/s1

InChI 密鑰

KUVIULQEHSCUHY-XYWKZLDCSA-N

基因資訊

human ... NR3C1(2908)

正在寻找类似产品? 访问 产品对比指南

一般說明

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.
For further information and support please go to the website of the issuing Pharmacopoeia.

應用

Beclometasone (beclomethasone) dipropionate BP Reference standard, intended for use in laboratory tests only as specifically prescribed in the British Pharmacopoeia.

Also used in monographs such as:
  • Beclometasone Pressurised Inhalation
  • Betamethasone and Clioquinol Cream
  • Betamethasone and Clioquinol Ointment
  • Betamethasone Valerate Cream
  • Betamethasone Valerate Ointment
  • Betamethasone Valerate Lotion
  • Beclometasone Inhalation Powder
  • Beclometasone Inhalation Powder, pre-metered
  • Clobetasol Cutaneous Foam
  • Betamethasone Valerate and Coal Tar Paste
  • Clobetasol Cream
  • Beclometasone Cream
  • Clobetasol Shampoo
  • Beclometasone Ointment
  • Clobetasol Scalp Application
  • Clobetasol Ointment
  • Beclometasone Aqueous Nasal Spray
  • 包裝

    Unit quantity: 100 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia

    其他說明

    Sales restrictions may apply.

    象形圖

    Health hazard

    訊號詞

    Warning

    危險聲明

    危險分類

    Repr. 2 - STOT RE 2

    標靶器官

    Adrenal gland,Immune system,Bone

    儲存類別代碼

    11 - Combustible Solids

    水污染物質分類(WGK)

    WGK 3

    閃點(°F)

    Not applicable

    閃點(°C)

    Not applicable


    Choose from one of the most recent versions:

    分析证书(COA)

    Lot/Batch Number

    Sorry, we don't have COAs for this product available online at this time.

    If you need assistance, please contact 客户支持

    已有该产品?

    在文件库中查找您最近购买产品的文档。

    访问文档库

    Dexter J D'Sa et al.
    Pharmaceutical research, 31(10), 2716-2723 (2014-04-25)
    The techniques available to study formulation stability in pressurized metered dose inhalers (pMDIs) are limited, due to the challenging conditions of working with high pressure propellants. Isothermal microcalorimetry is a valuable tool used to screen and aid in formulation development
    Carlos E Rodríguez-Martínez et al.
    Advances in therapy, 32(3), 254-269 (2015-03-11)
    Allergic rhinitis (AR) is one of the most common chronic respiratory diseases observed in the pediatric population, producing a significant morbidity, and an economic burden due to direct medical costs and indirect costs. Despite the high prevalence of AR in
    Bryn Flinders et al.
    Analytical and bioanalytical chemistry, 407(8), 2085-2094 (2014-11-05)
    Hydrazine-based derivatization reagents have been used to detect the presence of the carbonyl containing glucocorticoid fluticasone proprionate in rat lung tissue by MALDI-MSI. Such reagents also act as a matrix for analysis by MALDI-MS and have been termed "reactive matrices".

    我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

    联系技术服务部门